ES2180555T3 - Nueva substancia fisiologicamente activa. - Google Patents
Nueva substancia fisiologicamente activa.Info
- Publication number
- ES2180555T3 ES2180555T3 ES94115306T ES94115306T ES2180555T3 ES 2180555 T3 ES2180555 T3 ES 2180555T3 ES 94115306 T ES94115306 T ES 94115306T ES 94115306 T ES94115306 T ES 94115306T ES 2180555 T3 ES2180555 T3 ES 2180555T3
- Authority
- ES
- Spain
- Prior art keywords
- active substance
- physiologically active
- action
- agent
- blood flow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/13—Tumour cells, irrespective of tissue of origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
SE OFRECE UNA NUEVA SUSTANCIA FISIOLOGICAMENTE ACTIVA QUE EXHIBE UNA ACCION INHIBIDORA DE PRODUCCION DE ENZIMAS PROTEOLITICAS EN PLASMA, ACCION MEJORADORA DE FLUJO PERIFERICO EN SANGRE Y ACCIONES ANALGESICAS, ANTIINFLAMATORIAS Y ANTIALERGICAS. LA SUSTANCIA FISIOLOGICAMENTE ACTIVA DE LA PRESENTE INVENCION ES PREPARADA ACTIVANDO DIVERSOS ANIMALES O TEJIDOS ANIMALES POR MEDIO DE INOCULACION DE VIRUS O CELULAS TUMORALES QUE ACTUAN COMO UN AGRESIVO PSIQUICO Y ENTONCES EXTRAYENDO EL FACTOR EFECTIVO DE LOS TEJIDOS ACTIVADOS. LA INVENCION ES RELATIVA A UNA SUSTANCIA QUE EXHIBE UNA ACCION FARMACOLOGICA DE INHIBICION DE UNA ACTIVIDAD PARA LA PRODUCCION DE ENZIMAS PROTEOLITICAS EN PLASMA Y RECUPERA Y NORMALIZA LA FUNCION ANORMAL QUE RESULTA EN EL ESTADO DE ENFERMEDAD. LA SUSTANCIA FISIOLOGICAMENTE ACTIVA DE LA PRESENTE INVENCION EXHIBE UNA EXCELENTE ACTIVIDAD REGULADORA PARA BIOFUNCIONES, TIENE UNA ACCION DE RECUPERACION Y NORMALIZACION DE FUNCION ANORMAL DE LOS ORGANISMOS VIVOS EN DIVERSOS ESTADOS DEENFERMEDAD Y ES BASTANTE USADA COMO UN FARMACO TAL COMO UN AGENTE MEJORADOR DE FLUJO SANGUINEO, AGENTE ANALGESICO, AGENTE ANTIINFLAMATORIO Y AGENTE ANTIALERGICO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5265589A JP2594222B2 (ja) | 1993-09-28 | 1993-09-28 | 新規生理活性物質−kf |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2180555T3 true ES2180555T3 (es) | 2003-02-16 |
Family
ID=17419225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94115306T Expired - Lifetime ES2180555T3 (es) | 1993-09-28 | 1994-09-28 | Nueva substancia fisiologicamente activa. |
Country Status (14)
Country | Link |
---|---|
US (1) | US5560935A (es) |
EP (1) | EP0645142B1 (es) |
JP (1) | JP2594222B2 (es) |
KR (1) | KR100189144B1 (es) |
CN (1) | CN1062182C (es) |
AT (1) | ATE220913T1 (es) |
AU (1) | AU676081B2 (es) |
CA (1) | CA2132993C (es) |
DE (1) | DE69431024T2 (es) |
DK (1) | DK0645142T3 (es) |
ES (1) | ES2180555T3 (es) |
PT (1) | PT645142E (es) |
SG (1) | SG45225A1 (es) |
TW (1) | TW326028B (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2588109B2 (ja) * | 1993-03-19 | 1997-03-05 | 日本臓器製薬株式会社 | 鎮痛剤 |
JPH1084995A (ja) * | 1996-09-12 | 1998-04-07 | Nippon Zoki Pharmaceut Co Ltd | 血液凝固第xii因子活性化法 |
JP4033936B2 (ja) * | 1997-01-08 | 2008-01-16 | 日本臓器製薬株式会社 | 一酸化窒素産生抑制剤 |
JPH1180005A (ja) * | 1997-09-12 | 1999-03-23 | Nippon Zoki Pharmaceut Co Ltd | 骨粗鬆症治療剤 |
JPH11139977A (ja) * | 1997-11-07 | 1999-05-25 | Nippon Zoki Pharmaceut Co Ltd | Nef作用抑制剤 |
KR19990044835A (ko) * | 1997-11-28 | 1999-06-25 | 고니시 진우에몬 | 생약추출물 |
AU763224B2 (en) * | 1999-04-15 | 2003-07-17 | Nippon Zoki Pharmaceutical Co., Ltd. | Novel bioactivating substance |
EP1110909A1 (en) * | 1999-12-24 | 2001-06-27 | Bio Minerals N.V. | Method for preparing ortho silicic acid, ortho silicic acid as obtained, and its use |
US6726932B2 (en) | 2000-02-18 | 2004-04-27 | Nippon Zoki Pharmaceutical Co., Ltd. | Fatty acid-containing composition |
EP1420641A4 (en) * | 2001-08-01 | 2005-05-25 | Anil K Chauhan | IMMUNE COMPLEX |
US6913900B2 (en) * | 2001-08-29 | 2005-07-05 | Nippon Zoki Pharmaceutical Co., Ltd. | Plasma prekallikrein activation and kallikrein production assay |
AU2003280684B2 (en) | 2002-10-31 | 2009-06-25 | Nippon Zoki Pharmaceutical Co., Ltd. | Remedy for fibromyalgia |
CN1207005C (zh) | 2002-10-31 | 2005-06-22 | 威世药业(如皋)有限公司 | 含生物活性物质的兔皮和其用途 |
KR101307999B1 (ko) * | 2004-12-01 | 2013-09-12 | 니폰 조키 세야쿠 가부시키가이샤 | 건조물 및 그 제조방법 |
US20060134646A1 (en) | 2004-12-17 | 2006-06-22 | Ansari Aftab A | Method for treatment of HIV infection |
US7252834B2 (en) * | 2005-04-25 | 2007-08-07 | Clemson University Research Foundation (Curf) | Elastin stabilization of connective tissue |
TWI406664B (zh) | 2006-03-30 | 2013-09-01 | Univ Kyoto | 硫氧還蛋白(thioredoxin)產生促進劑 |
JP4300370B2 (ja) | 2007-03-13 | 2009-07-22 | 春三 小林 | 上皮改善剤 |
EP2191836B1 (en) | 2007-08-31 | 2012-05-23 | Kyushu University, National University Corporation | Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent |
TWI483729B (zh) | 2010-03-11 | 2015-05-11 | Nippon Zoki Pharmaceutical Co | 慢性前列腺炎、間質性膀胱炎及/或排尿障礙之改善或治療劑 |
WO2011162317A1 (ja) | 2010-06-25 | 2011-12-29 | 日本臓器製薬株式会社 | 被検物質の判定又は評価方法 |
EP2627343B1 (en) | 2010-10-14 | 2018-01-10 | Nippon Zoki Pharmaceutical Co., Ltd. | Agents for use for promoting the synthesis of collagen and proteoglycan in intervertebral disc cells |
CN103357006B (zh) | 2012-10-10 | 2014-10-15 | 日本脏器制药株式会社 | 含有提取物的制剂的检查方法 |
CA2909234C (en) | 2013-04-30 | 2023-03-14 | Nippon Zoki Pharmaceutical Co., Ltd. | Extracts and preparation thereof from inflamed skins of rabbits inoculated with vaccinia virus |
CN108738345A (zh) | 2016-02-24 | 2018-11-02 | 国立大学法人大阪大学 | 试验方法 |
WO2018056412A1 (ja) | 2016-09-23 | 2018-03-29 | 国立大学法人大阪大学 | シュワン細胞分化促進剤及び末梢神経再生促進剤 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB697351A (en) * | 1951-01-16 | 1953-09-23 | Masuichi Takino | Improved process for the manufacture of nerve sedatives |
US3959566A (en) * | 1974-10-21 | 1976-05-25 | E. I. Du Pont De Nemours And Company | Process for preparing polymeric surfaces to improve antistatic and soil resistant properties |
US4036787A (en) * | 1975-09-12 | 1977-07-19 | Blount David H | Process for the production of epoxy silicate compounds and polymers |
US4039474A (en) * | 1975-10-20 | 1977-08-02 | Nalco Chemical Company | Silica-alumina catalysts |
US4056937A (en) * | 1976-01-08 | 1977-11-08 | Kyokado Engineering Co. Ltd. | Method of consolidating soils |
US4089883A (en) * | 1976-07-09 | 1978-05-16 | Blount David H | Process for the production of organic hydroxy silicate compounds and their condensation products |
US4104456A (en) * | 1977-01-06 | 1978-08-01 | Blount David H | Process for the production of poly(allylhalide-allyl alcohol) |
JPS53101515A (en) * | 1977-02-17 | 1978-09-05 | Nippon Zoki Pharmaceutical Co | Medicine having anodyne * sedative and antiallergic activity and production thereof |
JPS5777697A (en) * | 1980-11-04 | 1982-05-15 | Nippon Zoki Pharmaceut Co Ltd | Physiologically active substance nsq |
JPS57183720A (en) * | 1981-05-01 | 1982-11-12 | Junji Mitani | Health drug for fish farming |
JPS5835117A (ja) * | 1981-08-25 | 1983-03-01 | Nippon Zoki Pharmaceut Co Ltd | 新規生理活性物質nsh |
JPS59118711A (ja) * | 1982-12-25 | 1984-07-09 | Nippon Zoki Pharmaceut Co Ltd | 新規生理活性物質 |
JPS63185398A (ja) * | 1986-09-10 | 1988-07-30 | Nippon Zoki Pharmaceut Co Ltd | 生理活性物質測定法 |
JP2651674B2 (ja) * | 1987-07-23 | 1997-09-10 | 日本臓器製薬 株式会社 | 新規生理活性物質及びその製造方法 |
US4863518A (en) * | 1987-10-19 | 1989-09-05 | Blount David H | Production of polyol-alkali metal silicate glass emulsion |
JP2539674B2 (ja) * | 1987-11-06 | 1996-10-02 | 日本臓器製薬株式会社 | 新規生理活性物質 |
US4985254A (en) * | 1987-11-06 | 1991-01-15 | Nippon Zoki Pharmaceutical Co., Ltd. | Method of treating ischemic diseases |
EP0341209B1 (en) * | 1988-04-30 | 1993-09-15 | Nippon Zoki Pharmaceutical Co. Ltd. | Physiologically active substances, a process for preparation and pharmaceutical compositions thereof |
SE461156B (sv) * | 1988-05-25 | 1990-01-15 | Eka Nobel Ab | Saett foer framstaellning av papper varvid formning och avvattning aeger rum i naervaro av en aluminiumfoerening, ett katjoniskt retentionsmedel och en polymer kiselsyra |
JP2539665B2 (ja) * | 1988-06-20 | 1996-10-02 | 日本臓器製薬株式会社 | 神経疾患治療剤 |
CA2052449C (en) * | 1990-10-01 | 2000-08-01 | Takao Hasegawa | Flocculant for water treatment and method for producing it |
-
1993
- 1993-09-28 JP JP5265589A patent/JP2594222B2/ja not_active Expired - Lifetime
-
1994
- 1994-09-23 TW TW083108799A patent/TW326028B/zh not_active IP Right Cessation
- 1994-09-27 CA CA002132993A patent/CA2132993C/en not_active Expired - Fee Related
- 1994-09-27 CN CN94116584A patent/CN1062182C/zh not_active Expired - Lifetime
- 1994-09-27 US US08/312,640 patent/US5560935A/en not_active Expired - Lifetime
- 1994-09-28 PT PT94115306T patent/PT645142E/pt unknown
- 1994-09-28 DK DK94115306T patent/DK0645142T3/da active
- 1994-09-28 KR KR1019940024623A patent/KR100189144B1/ko not_active IP Right Cessation
- 1994-09-28 AU AU74374/94A patent/AU676081B2/en not_active Ceased
- 1994-09-28 EP EP94115306A patent/EP0645142B1/en not_active Expired - Lifetime
- 1994-09-28 ES ES94115306T patent/ES2180555T3/es not_active Expired - Lifetime
- 1994-09-28 SG SG1996001681A patent/SG45225A1/en unknown
- 1994-09-28 AT AT94115306T patent/ATE220913T1/de not_active IP Right Cessation
- 1994-09-28 DE DE69431024T patent/DE69431024T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69431024T2 (de) | 2003-01-30 |
SG45225A1 (en) | 1998-01-16 |
EP0645142B1 (en) | 2002-07-24 |
CA2132993C (en) | 1999-10-26 |
AU7437494A (en) | 1995-04-13 |
DK0645142T3 (da) | 2002-11-04 |
KR960010010A (ko) | 1996-04-20 |
DE69431024D1 (de) | 2002-08-29 |
US5560935A (en) | 1996-10-01 |
CN1107365A (zh) | 1995-08-30 |
KR100189144B1 (ko) | 1999-06-01 |
JPH0797336A (ja) | 1995-04-11 |
PT645142E (pt) | 2002-12-31 |
JP2594222B2 (ja) | 1997-03-26 |
AU676081B2 (en) | 1997-02-27 |
CA2132993A1 (en) | 1995-03-29 |
TW326028B (en) | 1998-02-01 |
CN1062182C (zh) | 2001-02-21 |
ATE220913T1 (de) | 2002-08-15 |
EP0645142A1 (en) | 1995-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2180555T3 (es) | Nueva substancia fisiologicamente activa. | |
CY1119951T1 (el) | Συνθεσεις για αυξηση δραστηριοτητας τελομερασης και αγωγη λοιμωξης hiv | |
HUP9800028A2 (hu) | Több tumor esetében rendellenes sejtszaporodás előidézésében közrejátszó gének | |
DE69907508D1 (de) | Mikrobenbeständige und stabilisierte lösungen, die gamma-hydroxybuttersäuresalze zur behandlung von narkolepsie enthalten | |
DE69815122T2 (de) | Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen | |
DE68915834D1 (de) | Herstellung von T-Zellen und T-Zellmembranen, verwendbar zur Verhütung und Behandlung von Autoimmunkrankheiten. | |
ATE83659T1 (de) | Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus. | |
DE69528039D1 (de) | Inhibitoren der fettsäuresynthese als antimikrobielle mittel | |
ATE314063T1 (de) | Valproinsäure zur behandlung von brustkrebs, dickdarmkrebs, kopf-hals-krebs, kleinzelligem lungenkarzinom und blutzellenkrebs in kombination mit bestrahlung | |
BR0313371A (pt) | Composto, uso de um composto e método de tratamento de doença | |
Koundinya et al. | Effect of organophosphate pesticide Sumithion (Fenitrothion) on some aspects of carbohydrate metabolism in a freshwater fish, Sarotherodon (Tilapia) mossambicus (Peters) | |
DE502004008819D1 (de) | Medikament zur wachstumsinhibierung von tumoren | |
ATE412769T1 (de) | Nadh-oxidase als zielmolekül in diagnose und therapie | |
KR950700079A (ko) | 이식체-대-숙주 질환을 억제하기 위한 인터루킨-10의 용도(Use of interleukin-10 to suppress graft-vs. -host disease) | |
SE0102147D0 (sv) | New methods | |
HUP9901188A2 (hu) | Új, meghatározott enzimkeverékek sejtkinyeréshez és sebkezeléshez | |
ATE322244T1 (de) | Verwendung von polyaminosäurederivaten zur behandlung von seborrhoe und verwandten hautstörungen | |
AU664974B2 (en) | Accelerated wound healing | |
NO995838L (no) | Nye heteroetynylenforbindelser og farmasoeytiske og kosmetiske preparater inneholdende de samme | |
DE19681032D2 (de) | Gentherapeutisches Nukleinsäurekonstrukt, seine Herstellung und Verwendung zur Behandlung von Herzerkrankungen | |
DE602004030661D1 (de) | Verwendung von kahalalide verbindungen zur herstellung eines arzneimittels zur behandlung von psoriasis | |
DE50103012D1 (de) | Verwendung von hyaluronidase zur prophylaxe und behandlung von herz-kreislauf-erkrankungen | |
PT883406E (pt) | Utilizacao da il-7 no tratamento das doencas auto-imunes em particular a diabetes mellitus insulinodependente | |
DE69428797T2 (de) | Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden | |
DE69421705D1 (de) | Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen |